Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
320 articles
New review reveals HPV causes 60-70% of throat cancers in developed countries, with survival rates varying dramatically by cancer type.
Advanced gastric cancer treatments using immunotherapy and targeted drugs extend survival by 3-4 months beyond traditional chemotherapy.
Circulating tumor DNA testing identifies microscopic cancer remnants, predicting recurrence risk with remarkable accuracy.
Liquid biopsy using circulating tumor DNA shows promise for catching gastrointestinal cancer recurrence before symptoms appear.
Revolutionary liquid biopsy technologies show promise for catching GI cancers early through simple blood tests, potentially saving millions of lives.
New blood-based tests could revolutionize pancreatic cancer diagnosis by detecting biomarkers without tissue biopsies.
New research reveals how blocking specific enzymes could dramatically improve cancer immunotherapy effectiveness by removing immune suppression.
New research shows removing cost barriers significantly increases genetic testing uptake among cancer survivors' relatives.
Scientists discover how two microbes team up to accelerate colon cancer, but L-arginine may disrupt their deadly partnership.
New research reveals how cancer cells block immune-fighting structures, opening doors to better pancreatic cancer treatments.
New framework reveals why immune cells fail to control tumors in metabolically active tissues, opening paths for better treatments.
New research reveals how liver cancer develops, identifying immune-quiet and inflamed pathways that could enable early intervention.
